Targeted mutagenesis of the Vibrio fischeri flavin reductase FRase I to improve activation of the anticancer prodrug CB1954 von Swe, P.M., Copp, J.N., Green, L.K., Guise, C.P., Mowday, A.M., Smaill, J.B., Patterson, A.V., Ackerley, D.F.

Volltext

OC-0236: DTP-006: a novel, orally bioavailable hypoxia-activated prodrug von Niemans, R, Yaromina, A, Theys, J, Ashoorzadeh, A, Anderson, R, Bull, M, Guise, C, Hsu, H.L, Abbattista, M, Mowday, A, Patterson, A.V, Smaill, J.B, Ackerley, D.F, Dubois, L, Lambin, P

Volltext

SP-0136: Off target effects with hypoxia activated prodrugs: lessons learned from PR-104A von Mowday, A., Dubois, L., Smaill, J., Patterson, A., Lambin, P., Theys, J.

Volltext

OC-0562: Exploiting tumor DNA repair status and hypoxia with CP-506, a novel hypoxia-activated prodrug von Van der Wiel, A., Marcus, D., Niemans, R., Yaromina, A., Theys, J., Mowday, A., Ashoorzadeh, A., Anderson, R., Bull, M., Abbattista, M., Heyerick, A., Guise, C., Smaill, J., Patterson, A., Dubois, L., Lambin, P.

Volltext

OC-0591: Hypoxic cell killing by SN36506, a novel hypoxia-activated prodrug von Niemans, R., Yaromina, A., Theys, J., Ashoorzadeh, A., Anderson, R., Bull, M., Guise, C., Hsu, H.L., Abbattista, M., Mowday, A., Patterson, A.V., Smaill, J.B., Dubois, L., Lambin, P.

Volltext

EP-2327: Hypoxic cell killing by CP-506, a novel hypoxia-activated prodrug von Niemans, R., Yaromina, A., Theys, J., Marcus, D., Ashoorzadeh, A., Abbattista, M., Mowday, A., Biemans, R., Lieuwes, N., Deschoemaeker, S., Heyerick, A., Guise, C., Smaill, J.B., Patterson, A.V., Dubois, L., Lambin, P.

Volltext

Steiner education in Australia : maintaining an educational theory given the necessity of practice : Glenaeon Rudolf Steiner School, Sydney, 1957-2000 von Mowday, Glennis A

Volltext bestellen

Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy von Fu, Zhe, Mowday, Alexandra M, Smaill, Jeff B, Hermans, Ian F, Patterson, Adam V

Volltext

Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility von Williams, Elsie M, Little, Rory F, Mowday, Alexandra M, Rich, Michelle H, Chan-Hyams, Jasmine V E, Copp, Janine N, Smaill, Jeff B, Patterson, Adam V, Ackerley, David F

Volltext

将职业伦理对话提升到新高度：管理学会经验的反思 von Mowday, Richard T.

Volltext

Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302 von Meng, Fanying, Evans, James W, Bhupathi, Deepthi, Banica, Monica, Lan, Leslie, Lorente, Gustavo, Duan, Jian-Xin, Cai, Xiaohong, Mowday, Alexandra M, Guise, Christopher P, Maroz, Andrej, Anderson, Robert F, Patterson, Adam V, Stachelek, Gregory C, Glazer, Peter M, Matteucci, Mark D, Hart, Charles P

Volltext

Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery von Theys, Jan, Patterson, Adam V., Mowday, Alexandra M.

Volltext

Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress von Mowday, Alexandra M, Guise, Christopher P, Ackerley, David F, Minton, Nigel P, Lambin, Philippe, Dubois, Ludwig J, Theys, Jan, Smaill, Jeff B, Patterson, Adam V

Volltext

Engineering a Multifunctional Nitroreductase for Improved Activation of Prodrugs and PET Probes for Cancer Gene Therapy von Copp, Janine N., Mowday, Alexandra M., Williams, Elsie M., Guise, Christopher P., Ashoorzadeh, Amir, Sharrock, Abigail V., Flanagan, Jack U., Smaill, Jeff B., Patterson, Adam V., Ackerley, David F.

Volltext

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506 von van der Wiel, Alexander M A, Jackson-Patel, Victoria, Niemans, Raymon, Yaromina, Ala, Liu, Emily, Marcus, Damiënne, Mowday, Alexandra M, Lieuwes, Natasja G, Biemans, Rianne, Lin, Xiaojing, Fu, Zhe, Kumara, Sisira, Jochems, Arthur, Ashoorzadeh, Amir, Anderson, Robert F, Hicks, Kevin O, Bull, Matthew R, Abbattista, Maria R, Guise, Christopher P, Deschoemaeker, Sofie, Thiolloy, Sophie, Heyerick, Arne, Solivio, Morwena J, Balbo, Silvia, Smaill, Jeff B, Theys, Jan, Dubois, Ludwig J, Patterson, Adam V, Lambin, Philippe

Volltext

Design and Biological Evaluation of Piperazine-Bearing Nitrobenzamide Hypoxia/GDEPT Prodrugs: The Discovery of CP-506 von Ashoorzadeh, Amir, Mowday, Alexandra M, Abbattista, Maria R, Guise, Christopher P, Bull, Matthew R, Silva, Shevan, Patterson, Adam V, Smaill, Jeff B

Volltext

Introduction to Special Topic Forum: The Future of Work Motivation Theory von Steers, Richard M., Mowday, Richard T., Shapiro, Debra L.

Volltext

The Future of Work Motivation Theory von Steers, Richard M., Mowday, Richard T., Shapiro, Debra L.

Volltext

Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours von Mowday, Alexandra M., Dubois, Ludwig J., Kubiak, Aleksandra M., Chan-Hyams, Jasmine V. E., Guise, Christopher P., Ashoorzadeh, Amir, Lambin, Philippe, Ackerley, David F., Smaill, Jeff B., Minton, Nigel P., Theys, Jan, Patterson, Adam V.

Volltext

Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit von Singleton, Dean C., Mowday, Alexandra M., Guise, Chris P., Syddall, Sophie P., Bai, Sally Y., Li, Dan, Ashoorzadeh, Amir, Smaill, Jeff B., Wilson, William R., Patterson, Adam V.

Volltext